The role of colloidal delivery systems in DNA genetic therapeutics

Colloids in Biotechnology

Volumn , Issue , 2010, Pages 177-196

  Ho, Jenny ^a   Danquah, Michael K ^a   Huang, Yi ^a   Liu, Shan ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84888249151     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/EBK1439830802     Document Type: Chapter

References (160)

1. Allison, A. C. and G. Gregoriadis. 1974. Liposomes as immunological adjuvants. Nature 252:252-258.
2. Alpar, H. O., S. Somavarapu, K. N. Atuah, and V. Bramwell. 2005. Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery. Advanced Drug Delivery Reviews 57(3):411-430.
3. Bawarski, W. E., E. Chidlowsky, D. J. Bharali, and S. A. Mousa. 2008. Emerging nanopharmaceuticals. Nanomedicine-Nanotechnology Biology and Medicine 4(4):273-282.
4. Bergquist, C., E. L. Johansson, T. Lagergard, J. Holmgren, and A. Rudin. 1997. Intranasal vaccination of humans with recombinant cholera toxin B subunit induces systemic and local antibody responses in the upper respiratory tract and the vagina. Infection and Immunity 65(7):2676-2684.
5. Besseling, R., L. Isa, E. R. Weeks, and W. C. K. Poon. 2009. Quantitative imaging of colloidal flows. Advances in Colloid and Interface Science 146(1-2):1-17.
6. Bhavsar, M. D. and M. M. Amiji. 2007. Polymeric nano-and microparticle technologies for oral gene delivery. Expert Opinion on Drug Delivery 4(3):197-213.
7. Bivas-Benita, M., K. E. van Meijgaarden, K. L. M. C. Franken, H. E. Junginger, G. Borchard, T. H. M. Ottenhoff, and A. Geluk. 2004. Pulmonary delivery of chitosan-DNA nanoparticles enhances the immunogenicity of a DNA vaccine encoding HLA-A*0201-restricted T-cell epitopes of Mycobacterium tuberculosis. Vaccine 22(13-14):1609-1615.
8. Blaese, R. M., K. W. Culver, A. D. Miller, C. S. Carter, T. Fleisher, M. Clerici, G. Shearer et al. 1995. T-Lymphocytedirected gene-therapy for ADA-SCID-Initial trial results after 4 years. Science 270(5235):475-480.
9. Borchard, G. 2001. Chitosans for gene delivery. Advanced Drug Delivery Reviews 52(2):145-150.
10. Boussif, O., F. Lezoualch, M. A. Zanta, M. D. Mergny, D. Scherman, B. Demeneix, and J. P. Behr. 1995. A versatile vector for gene and oligonucleotide transfer into cells in culture and in-vivo: Polyethylenimine. Proceedings of the National Academy of Sciences of the United States of America 96(16):7297-7301.
11. Bowman, K. and K. W. Leong. 2006. Chitosan nanoparticles for oral drug and gene delivery. International Journal of Nanomedicine 1(2):117-128.
12. Boyaka, P. N., A. Tafaro, R. Fischer, K. Fujihashi, E. Jirillo, and J. R. McGhee. 2003. Therapeutic manipulation of the immune system: Enhancement of innate and adaptive mucosal immunity. Current Pharmaceutical Design 9(24):1965-1972.
13. Brigham, K. L., B. Meyrick, B. Christman, M. Magnuson, G. King, and L. C. Berry. 1989. In vivo transfection of murine lungs with a functioning prokaryotic gene using a liposome vehicle. American Journal of the Medical Sciences 298(4):278-281.
14. Burgess, D. J. 2006. Colloids and colloid drug delivery system. In Encyclopedia of Pharmaceutical Technology, eds. J. Swarbrick and J. C. Boylan, Informa Healthcare USA, Inc., New York.
15. Canonico, A. E., J. T. Conary, B. O. Meyrick, and K. L. Brigham. 1994. Aerosol and intravenous transfection of human alpha-1-antitrypsin gene to lungs of rabbits. American Journal of Respiratory Cell and Molecular Biology 10(1):24-29.
16. Chang, C. W., D. H. Choi, W. J. Kim, J. W. Yockman, L. V. Christensen, Y. H. Kim, and S. W. Kim. 2007. Nonionic amphiphilic biodegradable PEG-PLGA-PEG copolymer enhances gene delivery efficiency in rat skeletal muscle. Journal of Controlled Release 118(2):245-253.
17. Chen, H. M., V. Torchilin, and R. Langer. 1996. Lectin-bearing polymerized liposomes as potential oral vaccine carriers. Pharmaceutical Research 13(9):1378-1383.
18. Chen, J., W. L. Yang, G. Li, J. Qian, J. L. Xue, S. K. Fu, and D. R. Lu. 2004. Transfection of mEpo gene to intestinal epithelium in vivo mediated by oral delivery of chitosan-DNA nanoparticles. World Journal of Gastroenterology 10(1):112-116.
19. Chew, J. L., C. B. Wolfowicz, H. Q. Mao, K. W. Leong, and K. Y. Chua. 2003. Chitosan nanoparticles containing plasmid DNA encoding house dust mite allergen, Der p 1 for oral vaccination in mice. Vaccine 21(21-22):2720-2729.
20. Choi, J. S., D. K. Joo, C. H. Kim, K. Kim, and J. S. Park. 2000. Synthesis of a barbell-like triblock copolymer, poly(l-lysine) dendrimer-block-poly(ethylene glycol)-block-poly(l-lysine) dendrimer, and its selfassembly with plasmid DNA. Journal of the American Chemical Society 122(3):474-480.
21. Chorny, M., B. Polyak, I. S. Alferiev, K. Walsh, G. Friedman, and R. J. Levy. 2007. Magnetically driven plasmid DNA delivery with biodegradable polymeric nanoparticles. FASEB Journal 21(10):2510-2519.
22. Clark, A. R. and M. Egan. 1994. Modeling the deposition of inhaled powdered drug aerosols. Journal of Aerosol Science 25(1):175-186.
23. Connor, E. E., J. Mwamuka, A. Gole, C. J. Murphy, and M. D. Wyatt. 2005. Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Small 1:325-327.
24. Csaba, N., A. Sanchez, and M. J. Alonso. 2006. PLGA: Poloxamer and PLGA: Poloxamine blend nanostructures as carriers for nasal gene delivery. Journal of Controlled Release 113(2):164-172.
25. Davis, S. S. 2001. Nasal vaccines. Advanced Drug Delivery Reviews 51(1-3):21-42.
26. Davis, S. S. and L. Illum. 2003. Absorption enhancers for nasal drug delivery. Clinical Pharmacokinetics 42(13):1107-1128.
27. de Jonge, M. I., H. J. Hamstra, W. Jiskoot, P. Roholl, N. A. Williams, J. Dankert, L. van Alphen, and P. van der Ley. 2004. Intranasal immunisation of mice with liposomes containing recombinant meningococcal OpaB and OpaJ proteins. Vaccine 22(29-30):4021-4028.
28. de Lima, M. C. P., S. Simoes, P. Pires, H. Faneca, and N. Duzgunes. 2001. Cationic lipid-DNA complexes in gene delivery: From biophysics to biological applications. Advanced Drug Delivery Reviews 47(2-3):277-294.
29. Di Colo, G., Y. Zambito, and C. Zaino. 2008. Polymeric enhancers of mucosal epithelia permeability:Synthesis, transepithelial penetration-enhancing properties, mechanism of action, safety issues. Journal of Pharmaceutical Sciences 97(5):1652-1680.
30. Dubensky, T. W., M. A. Liu, and J. B. Ulmer. 2000. Delivery systems for gene-based vaccines. Molecular Medicine 6(9):723-732.
31. Dufes, C., I. F. Uchegbu, and A. G. Schatzlein. 2005. Dendrimers in gene delivery. Advanced Drug Delivery Reviews 57(15):2177-2202.
32. Dupuis, M., K. Denis-Mize, C. Woo, C. Goldbeck, M. J. Selby, M. C. Chen, G. R. Otten, J. B. Ulmer, J. J. Donnelly, G. Ott, and D. M. McDonald. 2000. Distribution of DNA vaccines determines their immunogenicity after intramuscular injection in mice. Journal of Immunology 165(5):2850-2858.
33. Edelstein, M. 2009. Gene Therapy Clinical Trials Worldwide. Wiley Inter Science, September 2008 [cited 30 March 2009]. Available from http://www.wiley.co.uk/genmed/clinical/
34. Edelstein, M. L., M. R. Abedi, J. Wixon, and R. M. Edelstein. 2004. Gene therapy clinical trials worldwide 1989-2004: An overview. Journal of Gene Medicine 6(6):597-602.
35. Edwards, D. A., J. Hanes, G. Caponetti, J. Hrkach, A. BenJebria, M. L. Eskew, J. Mintzes, D. Deaver, N. Lotan, and R. Langer. 1997. Large porous particles for pulmonary drug delivery. Science 276(5320):1868-1871.
36. Elfinger, M., S. Uezguen, and C. Rudolph. 2008. Nanocarriers for gene delivery: Polymer structure, targeting ligands and controlled-release devices. Current Nanoscience 4(4):322-353.
37. Felgner, P. L. 1996. Improvements in cationic liposomes for in vivo gene transfer. Human Gene Therapy 7(15):1791-1793.
38. Felgner, P. L., T. R. Gadek, M. Holm, R. Roman, H. W. Chan, M. Wenz, J. P. Northrop, G. M. Ringold, and M. Danielsen. 1987. Lipofection: A highly efficient, lipid-mediated DNA-transfection procedure. Proceedings of the National Academy of Sciences of the United States of America 84(21):7413-7417.
39. Fukunaka, Y., K. Iwanaga, K. Morimoto, M. Kakemi, and Y. Tabata. 2002. Controlled release of plasmid DNA from cationized gelatin hydrogels based on hydrogel degradation. Journal of Controlled Release 80(1-3):333-343.
40. Ghosh, P. S., C. K. Kim, G. Han, N. S. Forbes, and V. M. Rotello. 2008. Efficient gene delivery vectors by tuning the surface charge density of amino acid-functionalized gold nanoparticles. ACS Nano 2(11):2213-2218.
41. Godbey, W. T., K. K. Wu, and A. G. Mikos. 2001. Poly(ethylenimine)-mediated gene delivery affects endothelial cell function and viability. Biomaterials 22(5):471-480.
42. Gorman, C. M., M. Aikawa, B. Fox, E. Fox, C. Lapuz, B. Michaud, H. Nguyen, E. Roche, T. Sawa, and J. P. WienerKronish. 1997. Efficient in vivo delivery of DNA to pulmonary cells using the novel lipid EDMPC. Gene Therapy 4(9):983-992.
43. Goula, D., C. Benoist, S. Mantero, G. Merlo, G. Levi, and B. A. Demeneix. 1998. Polyethylenimine-based intravenous delivery of transgenes to mouse lung. Gene Therapy 5(9):1291-1295.
44. Gould-Fogerite, S., M. T. Kheiri, F. Zhang, Z. Wang, A. J. Scolpino, E. Feketeova, M. Canki, and R. J. Mannino. 1998. Targeting immune response induction with cochleate and liposome-based vaccines. Advanced Drug Delivery Reviews 32:273-287.
45. Goya, A. K., K. Khatri, N. Mishra, and S. P. Vyas. 2008. New patents on mucosal delivery of vaccines. Expert Opinion on Therapeutic Patents 18(11):1271-1288.
46. Gupta, M. and A. K. Gupta. 2004. Hydrogel pullulan nanoparticles encapsulating pBUDLacZ plasmid as an efficient gene delivery carrier. Journal of Controlled Release 99(1):157-166.
47. Gupta, A. K. and M. Gupta. 2005. Cytotoxicity suppression and cellular uptake enhancement of surface modified magnetic nanoparticles. Biomaterials 26(13):1565-1573.
48. Gupta, S. and S. P. Moulik. 2008. Biocompatible microemulsions and their prospective uses in drug delivery. Journal of Pharmaceutical Sciences 97(1):22-45.
49. Hacein-Bey-Abina, S., C. von Kalle, M. Schmidt, F. Le Deist, N. Wulffraat, E. McIntyre, I. Radford, J. L. Villeval, C. C. Fraser, M. Cavazzana-Calvo, and A. Fischer. 2003. A serious adverse event after successful gene therapy for x-linked severe combined immunodeficiency. New England Journal of Medicine 348(3):255-256.
50. He, X. W., F. Wang, L. Jiang, J. Li, S. K. Liu, Z. Y. Xiao, X. Q. Jin et al. 2005. Induction of mucosal and systemic immune response by single-dose oral immunization with biodegradable microparticles containing DNA encoding HBsAg. Journal of General Virology 86:601-610.
51. Helson, R., W. Olszewska, M. Singh, J. Z. Megede, J. A. Melero, D. O. Hagan, and P. J. M. Openshaw. 2008. Polylactide-co-glycolide (PLG) microparticles modify the immune response to DNA vaccination. Vaccine 26(6):753-761.
52. Ho, J., H. T. Wang, and G. M. Forde. 2008. Process considerations related to the microencapsulation of plasmid DNA via ultrasonic atomization. Biotechnology and Bioengineering 101(1):172-181.
53. Hofland, H. E. J., L. Shephard, and S. M. Sullivan. 1996. Formation of stable cationic lipid/DNA complexes for gene transfer. Proceedings of the National Academy of Sciences of the United States of America 93(14):7305-7309.
54. Hofland, H. E. J., D. Nagy, J. J. Liu, K. Spratt, Y. L. Lee, O. Danos, and S. M. Sullivan. 1997. In vivo gene transfer by intravenous administration of stable cationic lipid DNA complex. Pharmaceutical Research 14(6):742-749.
55. Holmgren, J. and C. Czerkinsky. 2005. Mucosal immunity and vaccines. Nature Medicine 11(4):S45-S53.
56. Huth, S., J. Lausier, S. W. Gersting, C. Rudolph, C. Plank, U. Welsch, and J. Rosenecker. 2004. Insights into the mechanism of magnetofection using PEI-based magnetofectins for gene transfer. Journal of Gene Medicine 6(8):923-936.
57. Hyde, S. C., I. A. Pringle, S. Abdullah, A. E. Lawton, L. A. Davies, A. Varathalingam, G. Nunez-Alonso et al. 2008. CpG-free plasmids confer reduced inflammation and sustained pulmonary gene expression. Nature Biotechnology 26(5):549-551.
58. Iqbal, M., W. Lin, I. Jabbal-Gill, S. S. Davis, M. W. Steward, and L. Illum. 2003. Nasal delivery of chitosan-DNA plasmid expressing epitopes of respiratory syncytial virus (RSV) induces protective CTL responses in BALB/c mice. Vaccine 21(13-14):1478-1485.
59. Jain, S. and S. P. Vyas. 2006. Mannosylated niosomes as adjuvant-carrier system for oral mucosal immunization. Journal of Liposome Research 16(4):331-345.
60. Jiang, X., H. Dai, C. Y. Ke, X. Mo, M. S. Torbenson, Z. P. Li, and H. Q. Mao. 2007. PEG-b-PPA/DNA micelles improve transgene expression in rat liver through intrabiliary infusion. Journal of Controlled Release 122(3):297-304.
61. Jilek, S., H. P. Merkle, and E. Walter. 2005. DNA-loaded biodegradable microparticles as vaccine delivery systems and their interaction with dendritic cells. Advanced Drug Delivery Reviews 57(3):377-390.
62. Jones, D. H., S. Corris, S. McDonald, J. C. S. Clegg, and G. H. Farrar. 1996. Poly(dl-lactide-co-glycolide)-encapsulated plasmid DNA elicits systemic and mucosal antibody responses to encoded protein after oral administration. Paper read at International Meeting on Nucleic Acid Vaccines for the Prevention of Infectious Diseases, February 05-07, Bethesda, MD.
63. Kabanov, A. V. and S. V. Vinogradov. 2009. Nanogels as pharmaceutical carriers: Finite networks of infinite capabilities. Angewandte Chemie-International Edition 48(30):5418-5429.
64. Kakizawa, Y. and K. Kataoka. 2002. Block copolymer micelles for delivery of gene and related compounds. Advanced Drug Delivery Reviews 54:203-222.
65. Kasper, F. K., S. K. Seidlits, A. Tang, R. S. Crowther, D. H. Carney, M. A. Barry, and A. G. Mikos. 2005. In vitro release of plasmid DNA from oligo(poly(ethylene glycol) fumarate) hydrogels. Journal of Controlled Release 104(3):521-539.
66. Kataoka, K., A. Harada, and Y. Nagasaki. 2001. Block copolymer micelles for drug delivery: Design, characterization and biological significance. Advanced Drug Delivery Reviews 47(1):113-131.
67. Katz, D. E., A. J. DeLorimier, M. K. Wolf, E. R. Hall, F. J. Cassels, J. E. van Hamont, R. Newcomer, M. A. Davachi, D. N. Taylor, and C. E. McQueen. 2003. Oral immunization of adult volunteers with microencapsulated enterotoxigenic Escherichia coli (ETEC) CS6 antigen. Vaccine 21(5-6):341-346.
68. Kersten, G. F. A. and D. J. A. Crommelin. 2003. Liposomes and ISCOMs. Vaccine 21(9-10):915-920.
69. Kievit, F. M., O. Veiseh, N. Bhattarai, C. Fang, J. W. Gunn, D. Lee, R. G. Ellenbogen, J. M. Olson, and M. Q. Zhang. 2009. PEI-PEG-chitosan-copolymer-coated iron oxide nanoparticles for safe gene delivery:Synthesis, complexation, and transfection. Advanced Functional Materials 19(14):2244-2251.
70. Kim, A., D. M. Checkla, P. Dehazya, and W. L. Chen. 2003. Characterization of DNA-hyaluronan matrix for sustained gene transfer. Journal of Controlled Release 90(1):81-95.
71. Kippax, P. and J. Fracassi. 2003. Particle size characterisation in nasal sprays and aerosols. In LabPlus International February/March.
72. Koping-Hoggard, M., K. M. Varum, M. Issa, S. Danielsen, B. E. Christensen, B. T. Stokke, and P. Artursson. 2004. Improved chitosan-mediated gene delivery based on easily dissociated chitosan polyplexes of highly defined chitosan oligomers. Gene Therapy 11(19):1441-1452.
73. Kozlowski, P. A., S. B. Williams, R. M. Lynch, T. P. Flanigan, R. R. Patterson, S. Cu-Uvin, and M. R. Neutra. 2002. Differential induction of mucosal and systemic antibody responses in women after nasal, rectal, or vaginal immunization: Influence of the menstrual cycle. Journal of Immunology 169(1):566-574.
74. KukowskaLatallo, J. F., A. U. Bielinska, J. Johnson, R. Spindler, D. A. Tomalia, and J. R. Baker. 1996. Efficient transfer of genetic material into mammalian cells using Starburst polyamidoamine dendrimers. Proceedings of the National Academy of Sciences of the United States of America 93(10):4897-4902.
75. Kumar, M., A. K. Behera, R. F. Lockey, J. Zhang, G. Bhullar, C. P. De La Cruz, L. C. Chen, K. W. Leong, S. K. Huang, and S. S. Mohapatra. 2002. Intranasal gene transfer by chitosan-DNA nanospheres protects BALB/c mice against acute respiratory syncytial virus infection. Human Gene Therapy 13(12):1415-1425.
76. Kumar, M. N. V. R., U. Bakowsky, and C. M. Lehr. 2004. Nanoparticles as non-viral transfection agents. In Nanobiotechnology: Concepts, Applications and Perspectives, eds. C. M. Niemeyer and C. A. Mirkin, Wiley-VCH, Weinheim, Germany.
77. Kushibiki, T., R. Tomoshige, Y. Fukunaka, M. Kakemi, and Y. Tabata. 2003. In vivo release and gene expression of plasmid DNA by hydrogels of gelatin with different cationization extents. Journal of Controlled Release 90(2):207-216.
78. Kushibiki, T., R. Tomoshige, K. Iwanaga, M. Kakemi, and Y. Tabata. 2006. Controlled release of plasmid DNA from hydrogels prepared from gelatin cationized by different amine compounds. Journal of Controlled Release 112(2):249-256.
79. Lambert, J. S., M. Keefer, M. J. Mulligan, D. Schwartz, J. Mestecky, K. Weinhold, C. Smith et al. 2001. A Phase I safety and immunogenicity trial of UBI (R) microparticulate monovalent HIV-1 MN oral peptide immunogen with parenteral boost in HIV-1 seronegative human subjects. Vaccine 19(23-24):3033-3042.
80. Ledley, F. D. 1996. Pharmaceutical approach to somatic gene therapy. Pharmaceutical Research 13(11):1595-1614.
81. Lemieux, P., N. Guerin, G. Paradis, R. Proulx, L. Chistyakova, A. Kabanov, and V. Alakhov. 2000a. A combination of poloxamers increases gene expression of plasmid DNA in skeletal muscle. Gene Therapy 7(11):986-991.
82. Lemieux, P., S. V. Vinogradov, C. L. Gebhart, N. Guerin, G. Paradis, H. K. Nguyen, B. Ochietti et al. 2000b. Block and graft copolymers and Nanogel (TM) copolymer networks for DNA delivery into cell. Journal of Drug Targeting 8(2):91-105.
83. Li, S., Y. D. Tan, E. Viroonchatapan, B. R. Pitt, and L. Huang. 2000. Targeted gene delivery to pulmonary endothelium by anti-PECAM antibody. American Journal of Physiology-Lung Cellular and Molecular Physiology 278(3):L504-L511.
84. Li, Z. H., W. Ning, J. M. Wang, A. Choi, P. Y. Lee, P. Tyagi, and L. Huang. 2003. Controlled gene delivery system based on thermosensitive biodegradable hydrogel. Pharmaceutical Research 20(6):884-888.
85. Li, P. C., D. Li, L. X. Zhang, G. P. Li, and E. K. Wang. 2008. Cationic lipid bilayer coated gold nanoparticlesmediated transfection of mammalian cells. Biomaterials 29(26):3617-3624.
86. Li, D., P. C. Li, G. P. Li, J. Wang, and E. K. Wang. 2009a. The effect of nocodazole on the transfection efficiency of lipid-bilayer coated gold nanoparticles. Biomaterials 30(7):1382-1388.
87. Li, G. P., Z. G. Liu, B. Liao, and N. S. Zhong. 2009b. Induction of Th1-type immune response by chitosan nanoparticles containing plasmid DNA encoding house dust mite allergen Der p 2 for oral vaccination in mice. Cellular & Molecular Immunology 6(1):45-50.
88. Lindner, L. H., R. Brock, D. Arndt-Jovin, and H. Eibl. 2006. Structural variation of cationic lipids:Minimum requirement for improved oligonucleotide delivery into cells. Journal of Controlled Release 110(2):444-456.
89. Liu, M. A. 2003. DNA vaccines: A review. Journal of Internal Medicine 253(4):402-410.
90. Liu, F., H. Qi, L. Huang, and D. Liu. 1997. Factors controlling the efficiency of cationic lipid-mediated transfection in vivo via intravenous administration. Gene Therapy 4(6):517-523.
91. Liu, M. A., B. Wahren, and G. B. K. Hedestam. 2006. DNA vaccines: Recent developments and future possibilities. Human Gene Therapy 17(11):1056-1061.
92. Lu, D. M. and A. J. Hickey. 2007. Pulmonary vaccine delivery. Expert Review of Vaccines 6(2):213-226.
93. Lu, Q. L., G. Bou-Gharios, and T. A. Partridge. 2003. Non-viral gene delivery in skeletal muscle: A protein factory. Gene Therapy 10(2):131-142.
94. Lungwitz, U., M. Breunig, T. Blunk, and A. Gopferich. 2005. Polyethylenimine-based non-viral gene delivery systems. European Journal of Pharmaceutics and Biopharmaceutics 60(2):247-266.
95. Luo, D. 2005. Nanotechnology and DNA delivery. MRS Bulletin 30(9):654-658.
96. MacGregor, R. R., J. D. Boyer, K. E. Ugen, K. E. Lacy, S. J. Gluckman, M. L. Bagarazzi, M. A. Chattergoon et al. 1998. First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: Safety and host response. Journal of Infectious Diseases 178(1):92-100.
97. MacLaughlin, F. C., R. J. Mumper, J. J. Wang, J. M. Tagliaferri, I. Gill, M. Hinchcliffe, and A. P. Rolland. 1998. Chitosan and depolymerized chitosan oligomers as condensing carriers for in vivo plasmid delivery. Journal of Controlled Release 56(1-3):259-272.
98. Mannino, R. J., E. S. Allebach, and W. A. Strohl. 1979. Encapsulation of high molecular-weight DNA in large unilamellar phospholipid-vesicles: Dependence on the size of the DNA. FEBS Letters 101(2):229-232.
99. May, S., D. Harries, and A. Ben-Shaul. 2000. The phase behavior of cationic lipid-DNA complexes. Biophysical Journal 78(4):1681-1697.
100. McNeil, S. E. and Y. Perrie. 2006. Gene delivery using cationic liposomes. Expert Opinion on Therapeutic Patents 16(10):1371-1382.
101. Megeed, Z., M. Haider, D. Q. Li, B. W. O’Malley, J. Cappello, and H. Ghandehari. 2004. In vitro and in vivo evaluation of recombinant silk-elastinlike hydrogels for cancer gene therapy. Journal of Controlled Release 94(2-3):433-445.
102. Mirchamsy, H., H. Manhouri, M. Hamedi, P. Ahourai, G. Fateh, and Z. Hamzeloo. 1996. Stimulating role of toxoids-laden liposomes in oral immunization against diphtheria and tetanus infections. Biologicals 24(4):343-350.
103. Miyata, K., S. Fukushima, N. Nishiyama, Y. Yamasaki, and K. Kataoka. 2007. PEG-based block catiomers possessing DNA anchoring and endosomal escaping functions to form polyplex micelles with improved stability and high transfection efficacy. Journal of Controlled Release 122(3):252-260.
104. Moore, A., E. Marecos, A. Bogdanov, and R. Weissleder. 2000. Tumoral distribution of long-circulating dextran-coated iron oxide nanoparticles in a rodent model. Radiology 214:568-574.
105. Mumper, R. J. and A. P. Rolland. 1998. Plasmid delivery to muscle: Recent advances in polymer delivery systems. Advanced Drug Delivery Reviews 30(1-3):151-172.
106. Mumper, R. J., J. G. Duguid, K. Anwer, M. K. Barron, H. Nitta, and A. P. Rolland. 1996. Polyvinyl derivatives as novel interactive polymers for controlled gene delivery to muscle. Pharmaceutical Research 13(5):701-709.
107. Mumper, R. J., J. J. Wang, S. L. Klakamp, H. Nitta, K. Anwer, F. Tagliaferri, and A. P. Rolland. 1998. Protective interactive noncondensing (PINC) polymers for enhanced plasmid distribution and expression in rat skeletal muscle. Journal of Controlled Release 52(1-2):191-203.
108. Nakanishi, M. and A. Noguchi. 2001. Confocal and probe microscopy to study gene transfection mediated by cationic liposomes with a cationic cholesterol derivative. Advanced Drug Delivery Reviews 52:197-207.
109. Newman, S. P., G. R. Pitcairn, and R. N. Dalby. 2004. Drug delivery to the nasal cavity: In vitro and in vivo assessment. Critical Reviews in Therapeutic Drug Carrier Systems 21(1):21-66.
110. Nguyen, D. N., J. J. Green, J. M. Chan, R. Langer, and D. G. Anderson. 2009. Polymeric materials for gene delivery and DNA vaccination. Advanced Materials 21(8):847-867.
111. Nishiyama, N. and K. Kataoka. 2006. Current state, achievements, and future prospects of polymeric micelles as nanocarriers for drug and gene delivery. Pharmacology & Therapeutics 112(3):630-648.
112. O’Hagan, D. T., M. Singh, and J. B. Ulmer. 2004. Microparticles for the delivery of DNA vaccines. Immunological Reviews 199(1):191-200.
113. O’Hagan, D. T., M. Singh, and J. B. Ulmer. 2006. Microparticle-based technologies for vaccines. Methods 40(1):10-19.
114. Oishi, M. and Y. Nagasaki. 2007. Synthesis, characterization, and biomedical applications of core-shell-type stimuli-responsive nanogels: Nanogel composed of poly[2-(N, N-diethylamino)ethyl methacrylate] core and PEG tethered chains. Reactive & Functional Polymers 67:1311-1329.
115. Oishi, M., K. Kataoka, and Y. Nagasaki. 2006. pH-Responsive three-layered PEGylated polyplex micelle based on a lactosylated ABC triblock copolymer as a targetable and endosome-disruptive nonviral gene vector. Bioconjugate Chemistry 17(3):677-688.
116. Oishi, M., H. Hayashi, K. Itaka, K. Kataoka, and Y. Nagasaki. 2007. pH-responsive PEGylated nanogels as targetable and low invasive endosomolytic agents to induce the enhanced transfection efficiency of nonviral gene vectors. Colloid and Polymer Science 285(9):1055-1060.
117. Opanasopit, P., M. Nishikawa, and M. Hashida. 2002. Factors affecting drug and gene delivery: Effects of interaction with blood components. Critical Reviews in Therapeutic Drug Carrier Systems 19(3):191-233.
118. Pal, R. 1996. Multiple O/W/O emulsion rheology. Langmuir 12(9):2220-2225.
119. Panyam, J. and V. Labhasetwar. 2003. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Advanced Drug Delivery Reviews 55(3):329-347.
120. Partidos, C. D. 2000. Intranasal vaccines: Forthcoming challenges. Pharmaceutical Science & Technology Today 3(8):273-281.
121. Patil, S. D., D. G. Rhodes, and D. J. Burgess. 2005. DNA-based therapeutics and DNA delivery systems: A comprehensive review. AAPS Journal 7(1):E61-E77.
122. Perrie, Y., P. M. Frederik, and G. Gregoriadis. 2001a. Liposome-mediated DNA vaccination: The effect of vesicle composition. Vaccine 19:3301-3310.
123. Perrie, Y., M. Obrenovic, D. McCarthy, and G. Gregoriadis. 2001b. Liposome (Lipodine (TM))-mediated DNA vaccination by the oral route. Paper read at 5th International Conference on Liposome Advances, December 17-21, London, U.K.
124. Petersen, H., K. Kunath, A. L. Martin, S. Stolnik, C. J. Roberts, M. C. Davies, and T. Kissel. 2002. Star-shaped poly(ethylene glycol)-block-polyethylenimine copolymers enhance DNA condensation of low molecular weight polyethylenimines. Biomacromolecules 3(5):926-936.
125. Pitard, B., H. Pollard, O. Agbulut, O. Lambert, J. T. Vilquin, Y. Cherel, J. Abadie, J. L. Samuel, J. L. Rigaud, S. Menoret, I. Anegon, and D. Escande. 2002. A nonionic amphiphile agent promotes gene delivery in vivo to skeletal and cardiac muscles. Human Gene Therapy 13(14):1767-1775.
126. Plautz, G. E., Z. Y. Yang, B. Y. Wu, X. Gao, L. Huang, and G. J. Nabel. 1993. Immunotherapy of malignancy by in vivo gene-transfer into tumors. Proceedings of the National Academy of Sciences of the United States of America 90(10):4645-4649.
127. Pouton, C. W. and L. W. Seymour. 2001. Key issues in non-viral gene delivery. Advanced Drug Delivery Reviews 46(1-3):187-203.
128. Prieto, J., M. Herraiz, B. Sangro, C. Qian, G. Mazzolini, I. Melero, and J. Ruiz. 2002. The promise of gene therapy in gastrointestinal and liver diseases. Paper read at European Institute of Healthcare Gastroenterology Symposium, April, Barcelona, Spain.
129. Raper, S. E., N. Chirmule, F. S. Lee, N. A. Wivel, A. Bagg, G. P. Gao, J. M. Wilson, and M. L. Batshaw. 2003. Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer. Molecular Genetics and Metabolism 80(1-2):148-158.
130. Ratanamart, J. and J. A. M. Shaw. 2006. Plasmid-mediated muscle-targeted gene therapy for circulating therapeutic protein replacement: A tale of the tortoise and the hare? Current Gene Therapy 6(1):93-110.
131. Richard, P., H. Pollard, C. Lanctin, M. Bello-Roufai, L. Desigaux, D. Escande, and B. Pitard. 2005. Inducible production of erythropoietin using intramuscular injection of block copolymer/DNA formulation. Journal of Gene Medicine 7(1):80-86.
132. Riera, M., M. Chillon, J. M. Aran, J. M. Cruzado, J. Torras, J. M. Grinyo, and C. Fillat. 2004. Intramuscular SP1017-formulated DNA electrotransfer enhances transgene expression and distributes hHGF to different rat tissues. Journal of Gene Medicine 6(1):111-118.
133. Rolland, A. 2005. Gene medicines: The end of the beginning? Advanced Drug Delivery Reviews 57(5):669-673.
134. Romano, G., P. Mitcheli, C. Pacilio, and A. Giordano. 2000. Latest developments in gene transfer technology:Achievements, perspectives, and controversies over therapeutic applications. Stem Cells 18(1):19-39.
135. Rosi, N. L., D. A. Giljohann, C. S. Thaxton, A. K. R. Lytton-Jean, M. S. Han, and C. A. Mirkin. 2006. Oligonucleotide-modified gold nanoparticles for intracellular gene regulation. Science 312:1027-1030.
136. Roy, K., H. Q. Mao, S. K. Huang, and K. W. Leong. 1999. Oral gene delivery with chitosan-DNA nanoparticles generates immunologic protection in a murine model of peanut allergy. Nature Medicine 5(4):387-391.
137. Sandhu, K. K., C. M. McIntosh, J. M. Simard, S. W. Smith, and V. M. Rotello. 2002. Gold nanoparticlemediated transfection of mammalian cells. Bioconjugate Chemistry 13(1):3-6.
138. Schillinger, U., T. Brill, C. Rudolph, S. Huth, S. Gersting, F. Krotz, J. Hirschberger, C. Bergemann, and C. Plank. 2005. Advances in magnetofection: Magnetically guided nucleic acid delivery. Journal of Magnetism and Magnetic Materials 293:501-508.
139. Segura, T., P. H. Chung, and L. D. Shea. 2005. DNA delivery from hyaluronic acid-collagen hydrogels via a substrate-mediated approach. Biomaterials 26(13):1575-1584.
140. Smith, J., Y. L. Zhang, and R. Niven. 1997. Toward development of a non-viral gene therapeutic. Advanced Drug Delivery Reviews 26(2-3):135-150.
141. Stern, M., K. Ulrich, D. M. Geddes, and E. W. F. W. Alton. 2003. Poly (d, l-lactide-co-glycolide)/DNA microspheres to facilitate prolonged transgene expression in airway epithelium in vitro, ex vivo and in vivo. Gene Therapy 10(16):1282-1288.
142. Tahara, K., H. Yamamoto, H. Takeuchi, and Y. Kawashima. 2007. Development of gene delivery system using PLGA nanospheres. Yakugaku Zasshi-Journal of the Pharmaceutical Society of Japan 127:1541-1548.
143. Tamilvanan, S. 2004. Oil-in-water lipid emulsions: Implications for parenteral and ocular delivering systems. Progress in Lipid Research 43(6):489-533.
144. Tang, G. P., J. M. Zeng, S. J. Gao, Y. X. Ma, L. Shi, Y. Li, H. P. Too, and S. Wang. 2003. Polyethylene glycol modified polyethylenimine for improved CNS gene transfer: Effects of PEGylation extent. Biomaterials 24(13):2351-2362.
145. Thierry, A. R., E. Vives, J. P. Richard, P. Prevot, C. Martinand-Mari, I. Robbins, and B. Lebleu. 2003. Cellular uptake and intracellular fate of antisense oligonucleotides. Current Opinion in Molecular Therapeutics 5(2):133-138.
146. Thomas, M. and A. M. Klibanov. 2003. Conjugation to gold nanoparticles enhances polyethylenimine’s transfer of plasmid DNA into mammalian cells. Proceedings of The National Academy of Sciences of the United States of America 100:9138-9143.
147. Turker, S., E. Onur, and Y. Ozer. 2004. Nasal route and drug delivery systems. Pharmacy World & Science 26(3):137-142.
148. Ulrich, A. S. 2002. Biophysical aspects of using liposomes as delivery vehicles. Bioscience Reports 22(2):129-150.
149. Vadolas, J., J. K. Davies, P. J. Wright, and R. A. Strugnell. 1995. Intranasal immunization with liposomes induces strong mucosal immune-responses in mice. European Journal of Immunology 25(4):969-975.
150. Venkatesan, N. and S. P. Vyas. 2000. Polysaccharide coated liposomes for oral immunization: Development and characterization. International Journal of Pharmaceutics 203(1-2):169-177.
151. Vila, A., A. Sanchez, C. Evora, I. Soriano, J. L. V. Jato, and M. J. Alonso. 2004. PEG-PLA nanoparticles as carriers for nasal vaccine delivery. Journal of Aerosol Medicine-Deposition Clearance and Effects in the Lung 17(2):174-185.
152. Vinogradov, S. V. 2006. Colloidal microgels in drug delivery applications. Current Pharmaceutical Design 12(36):4703-4712.
153. Wagner, E., M. Cotten, R. Foisner, and M. L. Birnstiel. 1991. Transferrin polycation DNA complexes: The effect of polycations on the structure of the complex and DNA delivery to cells. Proceedings of the National Academy of Sciences of the United States of America 88(10):4255-4259.
154. Wang, H., Y. Chen, X. Y. Li, and Y. Liu. 2007. Synthesis of oligo(ethylenediamino)-beta-cyclodextrin modified gold nanoparticle as a DNA concentrator. Molecular Pharmaceutics 4(2):189-198.
155. Wheeler, C. J., P. L. Felgner, Y. J. Tsai, J. Marshall, L. Sukhu, S. G. Doh, J. Hartikka et al. 1996. A novel cationic lipid greatly enhances plasmid DNA delivery and expression in mouse lung. Proceedings of the National Academy of Sciences of the United States of America 93(21):11454-11459.
156. Wieland, J. A., T. L. Houchin-Ray, and L. D. Shea. 2007. Non-viral vector delivery from PEG-hyaluronic acid hydrogels. Journal of Controlled Release 120(3):233-241.
157. Wigglesworth, T. J., F. Teixeira, F. Axthelm, S. Eisler, N. S. Csaba, H. P. Merkle, W. Meier, and F. Diederich. 2008. Dendronised block copolymers as potential vectors for gene transfection. Organic & Biomolecular Chemistry 6(11):1905-1911.
158. Wolfert, M. A. and L. W. Seymour. 1996. Atomic force microscopic analysis of the influence of the molecular weight of poly(l)lysine on the size of polyelectrolyte complexes formed with DNA. Gene Therapy 3(3):269-273.
159. Xiang, J. J., J. Q. Tang, S. G. Zhu, X. M. Nie, H. B. Lu, S. R. Shen, X. L. Li, K. Tang, M. Zhou, and G. Y. Li. 2003. IONP-PLL: A novel non-viral vector for efficient gene delivery. The Journal of Gene Medicine 5(9):803-817.
160. Zauner, W., M. Ogris, and E. Wagner. 1998. Polylysine-based transfection systems utilizing receptor-mediated delivery. Advanced Drug Delivery Reviews 30(1-3):97-113.